| 注册
首页|期刊导航|应用化学|紫杉醇治疗非小细胞肺癌研究的知识图谱演进、热点及趋势分析

紫杉醇治疗非小细胞肺癌研究的知识图谱演进、热点及趋势分析

谢铮 张璐 高艺 李豪 胥皓为 张馨丹 刘天宇 赫玉芳

应用化学2026,Vol.43Issue(9):1543-1558,16.
✕
应用化学2026,Vol.43Issue(9):1543-1558,16.

紫杉醇治疗非小细胞肺癌研究的知识图谱演进、热点及趋势分析

Knowledge Graph Evolution,Hotspots,and Trend Analysis of Research on Paclitaxel in the Treatment of Non-Small Cell Lung Cancer

谢铮 1张璐 1高艺 1李豪 2胥皓为 1张馨丹 1刘天宇 3赫玉芳1

作者信息

  • 1. 长春中医药大学管理学院,长春 130117
  • 2. 长春中医药大学药学院,长春 130117
  • 3. 上海蓬海涞讯数据技术有限公司,上海 200032
  • 折叠

摘要

Abstract

Using bibliometric methods,this study systematically reviews the current state of research,evolving trends and future directions in the field of paclitaxel treatment for non-small cell lung cancer(NSCLC).Relevant Chinese and English literature from China National Knowledge Infrastructure(CNKI)and the Web of Science(WOS)Core Collection up to May 2026 was retrieved.CiteSpace 6.3.R1,VOSviewer 1.6.20.0 and Excel were utilised to conduct visual analyses of annual publication volume,research institutions,author collaboration,country distribution,keyword co-occurrence,clustering and emergence.The findings revealed that both Chinese and English literature exhibited a'germination-growth-plateau-decline'pattern,with the total volume of English literature significantly exceeding that of Chinese.International research has formed a high-intensity collaborative network centred on the United States.Research hotspots revolve around paclitaxel combined with platinum-based chemotherapy;English-language research places greater emphasis on cutting-edge topics such as randomised controlled trials,survival outcomes,targeted therapy,immunotherapy and nanomedicine,whilst Chinese-language research primarily focuses on efficacy,safety and localised clinical evaluation.Emergent terms indicate that international cutting-edge research has shifted from the comparison of chemotherapy regimens to combination therapy with immune checkpoint inhibitors.The field of paclitaxel treatment for NSCLC is transitioning from the optimisation of traditional chemotherapy towards a new phase characterised by the concurrent advancement of precision medicine,integrated approaches and translational research.Future efforts should strengthen biomarker screening,the elucidation of resistance mechanisms,and the integration of real-world evidence with high-quality clinical trials.

关键词

紫杉醇/非小细胞肺癌/知识图谱/前沿趋势

Key words

Paclitaxel/Non-small cell lung cancer/Knowledge graph/Cutting-edge trends

分类

化学化工

引用本文复制引用

谢铮,张璐,高艺,李豪,胥皓为,张馨丹,刘天宇,赫玉芳..紫杉醇治疗非小细胞肺癌研究的知识图谱演进、热点及趋势分析[J].应用化学,2026,43(9):1543-1558,16.

应用化学

1000-0518

访问量0
|
下载量0
段落导航相关论文